Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (NY:ENZ)

0.3138 UNCHANGED
Last Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem (NYSE: ENZ) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
From Enzo Biochem, Inc.
Via GlobeNewswire
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
From Enzo Biochem, Inc.
Via GlobeNewswire
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
From Enzo Biochem, Inc.
Via GlobeNewswire
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
From Enzo Biochem, Inc.
Via GlobeNewswire
Federman & Sherwood Investigates Enzo Biochem for Data Breach
From Federman & Sherwood
Via Business Wire
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
From Enzo Biochem, Inc.
Via GlobeNewswire
Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW
From Farmer Bros. Co.
Via GlobeNewswire
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
- David Bench resigning to pursue a new career opportunity - 
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
From Enzo Biochem, Inc.
Via GlobeNewswire
Bradley L. Radoff Issues Letter to the Independent Directors of Enzo Biochem Regarding Their Unwillingness to Acknowledge or Address Unprecedented Shareholder Unrest
From Bradley L. Radoff
Via Business Wire
Bradley L. Radoff Issues Open Letter to Recently-Appointed Independent Directors of Enzo Biochem
From Radoff Group
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.